Siberia | Technology & innovation

Scientists offer solution to blood circulation problems

1 Feb '19
Scientists at the Institute of Biology in the northwestern Russian region of Komi and their colleagues in Tomsk, in Siberia, have developed a pharmacological substance that is likely to become the basis of a new drug candidate to treat blood circulation disorders. The recently patented substance is called “Dibornol”.

Their product shows “antioxidative, hemorrheological, antithrombogenic, neuroprotective and retina-protective activities, thus improving the properties of blood and increasing cerebral blood flow for effective treatment of patients with chronic blood circulation disorders,” said Academician Alexander Kuchin, a professor and the leader of the research team that worked on the substance for more than 10 years.

Three-year preclinical trials conducted in partnership with the Institute of Pharmacology and Regenerative Medicine in Tomsk have led the team to believe that “there’s no analog in the global pharmaceutical market to match the combination of the new drug candidate’s useful properties.”

The Dibornol is a semi-synthetic substance derived from natural raw material (turpentine components).

Clinical trial phase testing is expected to take between five and seven years.
Publish in Twitter
Write to Facebook
Google Buzz
Write to LiveJournal
Show in MM
Share MK
COMMENT ON THIS STORY
Find Related Content

Locations: Komi; Tomsk

Tags: pharmacological substance (0) / blood circulation disorders (0) / Dibornol (0) / Alexander Kuchin (0) /

Latest News: Siberia
4 Feb '19 | Technology & innovation
1 Feb '19 | Technology & innovation
22 Jan '19 | Technology & innovation
24 Dec '18 | Technology & innovation
23 Aug '18 | Technology & innovation
 

Feature stories

29 Jan '19
Russian biologists and biophysicists have developed...
2 Nov '18
Drawing upon in-depth interviews, the book channels...
27 Aug '18
Search (News archive - 21321)
Advertising
RB_Partners_Report
Advertising
Annex_to_RB_Partners_Report
Advertising
NATT
Advertising
Independent Software Developers Forum
Advertising
Marchmont News

Latest News

22 Feb '19
A Russian company has developed a neuroset-aided...
21 Feb '19
Chemists in Moscow have developed ceramic matrices, a...
20 Feb '19
A Russian government agency teams up with private...

Most read stories from last week

22 Feb '19
A Russian company has developed a neuroset-aided...
21 Feb '19
Chemists in Moscow have developed ceramic matrices, a...